When Chinese drug developers need to see exactly how an experimental medicine binds to its target protein, or materials ...

From biotech millionaire to presidential candidate… and now a frontrunner in the race to become Ohio’s next governor. Vivek ...

The Indian government has published a 10-year national bioeconomy roadmap sector, which includes a focus on alternative ...

The company says recent investments in manufacturing and overseas expansion should start paying off over the next few ...

Defence Minister Rajnath Singh hailed India as the "Pharmacy of the World" while addressing an event organised by the Indian ...

Startups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners ...

Replimune gutted its entire sales and marketing team after the FDA rejected its melanoma treatment for a second time. Now the ...

Clearmind Medicine Inc. (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogenderived treatments for Alcohol Use Disorder (AUD), addiction, and weight ...

Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers.

The Energy Regulatory Commission (ERC) has temporarily suspended the power delivery service (PDS) charges for qualified energy storage systems (ESS) to support grid reliability. The commission noted ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ('Gain”, or the 'Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...

Every so often, a wave of demand in one corner of medicine spills over and creates an entirely new market next ...